Pages that link to "Q34241230"
Jump to navigation
Jump to search
The following pages link to Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release (Q34241230):
Displaying 50 items.
- The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond (Q26851645) (← links)
- Multifunctional nanoparticles for brain tumor imaging and therapy (Q26865418) (← links)
- Nanomedicine therapeutic approaches to overcome cancer drug resistance (Q27011692) (← links)
- Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers (Q28478066) (← links)
- Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer (Q28480835) (← links)
- MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain (Q29248327) (← links)
- NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. (Q30352890) (← links)
- Bionanotechnology and the future of glioma (Q30417964) (← links)
- Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. (Q33657689) (← links)
- Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment. (Q33705431) (← links)
- Dual-targeted peptide-conjugated multifunctional fluorescent probe with AIEgen for efficient nucleus-specific imaging and long-term tracing of cancer cells (Q33800277) (← links)
- Biocompatible nanopolymers: the next generation of breast cancer treatment? (Q33864065) (← links)
- Polymalic acid-based nano biopolymers for targeting of multiple tumor markers: an opportunity for personalized medicine? (Q33987367) (← links)
- Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies (Q34001049) (← links)
- Nanoparticles of esterified polymalic acid for controlled anticancer drug release. (Q34156543) (← links)
- Imaging of cells and nanoparticles: implications for drug delivery to the brain (Q34340761) (← links)
- Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity (Q36191573) (← links)
- Economic co-production of poly(malic acid) and pullulan from Jerusalem artichoke tuber by Aureobasidium pullulans HA-4D. (Q36288867) (← links)
- Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid) (Q36321843) (← links)
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer. (Q36406637) (← links)
- Nanotechnology in corneal neovascularization therapy--a review (Q36696450) (← links)
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translation (Q36934007) (← links)
- Nanotechnology-novel therapeutics for CNS disorders (Q37173643) (← links)
- Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate (Q37334071) (← links)
- Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? (Q37334865) (← links)
- Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer (Q37678070) (← links)
- Nanobiotechnology and Personalized Medicine (Q37957326) (← links)
- Making sense of therapeutics using antisense technology (Q38014478) (← links)
- Nanobiotechnology-based strategies for crossing the blood-brain barrier (Q38038895) (← links)
- The future of glioma treatment: stem cells, nanotechnology and personalized medicine (Q38048888) (← links)
- CNS drug targeting: have we travelled in right path? (Q38127262) (← links)
- Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers (Q38228137) (← links)
- Strategies for overcoming the blood-brain barrier for the treatment of brain metastases (Q38233077) (← links)
- pH-responsive drug-delivery systems (Q38258883) (← links)
- Antibody-targeted biodegradable nanoparticles for cancer therapy (Q38665261) (← links)
- Poly(malic acid) bearing Doxorubicin and N-Acetyl Galactosamine as a site-specific prodrug for targeting hepatocellular carcinoma (Q38709628) (← links)
- A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation (Q38830917) (← links)
- Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease (Q39047248) (← links)
- Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria. (Q39092142) (← links)
- Covalent nano delivery systems for selective imaging and treatment of brain tumors (Q39367664) (← links)
- Novel biodegradable and pH-sensitive poly(ester amide) microspheres for oral insulin delivery (Q39390938) (← links)
- Poly(methyl malate) Nanoparticles: Formation, Degradation, and Encapsulation of Anticancer Drugs (Q39500118) (← links)
- Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers (Q39537001) (← links)
- New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery (Q39546672) (← links)
- Quantitative analysis of PMLA nanoconjugate components after backbone cleavage (Q40458529) (← links)
- Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA. (Q40461207) (← links)
- Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles (Q40887277) (← links)
- The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery (Q41922949) (← links)
- Design of smart HPMA copolymer-based nanomedicines (Q42553783) (← links)
- Polymalic Acid Tritryptophan Copolymer Interacts with Lipid Membrane Resulting in Membrane Solubilization (Q42631516) (← links)